Friday 27th June 2025 13:00 - 14:00 (BST)
Gene therapy has long been heralded as a game-changer in rare disease treatment, yet the path from scientific breakthrough to real-world impact remains complex. The field has seen remarkable advancements, including ‘non-rare’ diseases, while challenges in access, affordability, regulation, and clinical implementation persist.
This 60-minute masterclass will examine whether gene therapy is meeting expectations or if hurdles such as high costs, limited patient access, and uncertain long-term outcomes are slowing progress.
Our expert panel will discuss how the Life Sciences industry, healthcare systems, and policymakers must adapt to make gene therapies a viable reality.
27th Jun 2025 13:00 – 14:00 (BST)
Speakers
CEO, Gene People
Managing Director, Oxygen Strategy
Director, Advanced Therapy Treatment Centre Network Coordination - Cell & Gene Therapy Catapult
Global Vice President of Market Access AscellaHealth
Former Member of the Board of Advisors, ATMPS | Director at NJ Redfern Ltd
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now